Stockreport

Invivyd (IVVD) Is Up 34.4% After FDA Clears Late-Stage COVID Antibody Program—What's Changed [Yahoo! Finance]

Invivyd, Inc.  (IVVD) 
PDF clinical program for VYD2311, a monoclonal antibody alternative to COVID-19 vaccines, to proceed with two late-stage clinical trials planned for year-end 2025. This mo [Read more]